Medline - Class A (MDLN) closed at $34.09 on November 3, 2026, up 1.4% from the previous close, on volume of 13,031,746 shares (30-day average 8,682,806).
Data as of November 3, 2026.
3-Nov-2026
Medline Inc. Q3 2026 Earnings Preview
Seeking Alpha News (Tue, 3-Nov 9:46 AM ET)
Medline announces participation in the 2026 Jefferies Global Healthcare Conference
Globe Newswire (Mon, 2-Nov 4:15 PM ET)
Globe Newswire (Fri, 30-Oct 6:18 AM ET)
Globe Newswire (Wed, 28-Oct 6:46 AM ET)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
Globe Newswire (Tue, 27-Oct 5:54 PM ET)
Globe Newswire (Mon, 26-Oct 5:46 AM ET)
Globe Newswire (Fri, 23-Oct 6:33 AM ET)
Globe Newswire (Wed, 21-Oct 5:46 AM ET)
Globe Newswire (Mon, 19-Oct 6:07 AM ET)
Globe Newswire (Fri, 16-Oct 6:18 AM ET)
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Medline - Class A trades on the NASDAQ stock market under the symbol MDLN.
As of November 3, 2026, MDLN stock price climbed to $34.09 with 13,031,746 million shares trading.
MDLN has a beta of 0.94, meaning it tends to be less sensitive to market movements. MDLN has a correlation of 0.06 to the broad based SPY ETF.
MDLN has a market cap of $29.91 billion. This is considered a Large Cap stock.
Last quarter Medline - Class A reported $8 billion in Revenue and $.50 earnings per share. This beat revenue expectation by $172 million and exceeded earnings estimates by $.18.
The top ETF exchange traded funds that MDLN belongs to (by Net Assets): VTI, VO, VXF, VTV, VOE.
MDLN support price is $32.87 and resistance is $34.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDLN shares will trade within this expected range on the day.
